{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T06:03:11Z","timestamp":1782540191463,"version":"3.54.5"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T00:00:00Z","timestamp":1693872000000},"content-version":"am","delay-in-days":369,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008143","name":"Oregon National Primate Research Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008143","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.jaci.2022.02.027","type":"journal-article","created":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T03:16:11Z","timestamp":1647314171000},"page":"640-648","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Signaling sphingolipids are biomarkers for atopic dermatitis prone to disseminated viral infections"],"prefix":"10.1016","volume":"150","author":[{"given":"Evgeny","family":"Berdyshev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Goleva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Bronova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Sofia","family":"Bronoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne E.","family":"Streib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn A.","family":"Vang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany N.","family":"Richers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Villarreal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keli","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark K.","family":"Slifka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Hanifin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald Y.M.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2022.02.027_bib1","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.jaci.2017.01.008","article-title":"Clinical phenotypes and endophenotypes of atopic dermatitis: where are we, and where should we go?","volume":"139","author":"Bieber","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.02.027_bib2","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0140-6736(20)31286-1","article-title":"Atopic dermatitis","volume":"396","author":"Langan","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2022.02.027_bib3","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jaci.2009.05.020","article-title":"Phenotype of atopic dermatitis subjects with a history of eczema herpeticum","volume":"124","author":"Beck","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.02.027_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.anai.2020.08.002","article-title":"The infectious complications of atopic dermatitis","volume":"126","author":"Wang","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2022.02.027_bib5","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1093\/cid\/cir952","article-title":"Eczema vaccinatum","volume":"54","author":"Reed","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaci.2022.02.027_bib6","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jaci.2007.04.031","article-title":"Cytokine modulation of atopic dermatitis filaggrin skin expression","volume":"120","author":"Howell","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.02.027_bib7","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.jaci.2014.12.1923","article-title":"Filaggrin deficiency promotes the dissemination of cutaneously inoculated vaccinia virus","volume":"135","author":"Oyoshi","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.02.027_bib8","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13148-019-0714-1","article-title":"Replicated methylation changes associated with eczema herpeticum and allergic response","volume":"11","author":"Boorgula","year":"2019","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.jaci.2022.02.027_bib9","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jaci.2010.10.033","article-title":"Comparative proteomic profiling of patients with atopic dermatitis based on history of eczema herpeticum infection and Staphylococcus aureus colonization","volume":"127","author":"Broccardo","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.02.027_bib10","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/intimm\/dxz037","article-title":"Sphingosine 1-phosphate and inflammation","volume":"31","author":"Obinata","year":"2019","journal-title":"Int Immunol"},{"key":"10.1016\/j.jaci.2022.02.027_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jns.2013.02.011","article-title":"Fingolimod: direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy","volume":"328","author":"Groves","year":"2013","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jaci.2022.02.027_bib12","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.antiviral.2012.05.006","article-title":"SKI-1\/S1P inhibition: a promising surrogate to statins to block hepatitis C virus replication","volume":"95","author":"Blanchet","year":"2012","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jaci.2022.02.027_bib13","doi-asserted-by":"crossref","first-page":"8124","DOI":"10.1128\/JVI.00510-10","article-title":"Sphingosine 1-phosphate-metabolizing enzymes control influenza virus propagation and viral cytopathogenicity","volume":"84","author":"Seo","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.jaci.2022.02.027_bib14","doi-asserted-by":"crossref","first-page":"677","DOI":"10.4049\/jimmunol.1601959","article-title":"Sphingosine 1-phosphate lyase enhances the activation of IKKepsilon to promote type I IFN-mediated innate immune responses to influenza A\u00a0virus infection","volume":"199","author":"Vijayan","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2022.02.027_bib15","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1172\/JCI125297","article-title":"Sphingosine kinase 2 restricts T cell immunopathology but permits viral persistence","volume":"130","author":"Studstill","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2022.02.027_bib16","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jneuroim.2018.12.009","article-title":"The frequency of varicella-zoster virus infection in patients with multiple sclerosis receiving fingolimod","volume":"328","author":"Aramideh Khouy","year":"2019","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jaci.2022.02.027_bib17","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1177\/1352458518807088","article-title":"Warts and all: fingolimod and unusual HPV-associated lesions","volume":"25","author":"Triplett","year":"2019","journal-title":"Mult Scler"},{"key":"10.1016\/j.jaci.2022.02.027_bib18","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.msard.2018.04.008","article-title":"Severe aseptic temporal lobe encephalitis on fingolimod","volume":"23","author":"Rotstein","year":"2018","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.jaci.2022.02.027_bib19","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.msard.2016.08.003","article-title":"Hepatitis C virus (HCV) reactivation during fingolimod treatment for relapsing and remitting multiple sclerosis","volume":"9","author":"Tagawa","year":"2016","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.jaci.2022.02.027_bib20","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1165\/rcmb.2012-0411TR","article-title":"Sphingosine-1-phosphate, FTY720, and sphingosine-1-phosphate receptors\u00a0in the pathobiology of acute lung injury","volume":"49","author":"Natarajan","year":"2013","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jaci.2022.02.027_bib21","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.98006","article-title":"Lipid abnormalities in atopic skin are driven by type 2 cytokines","volume":"3","author":"Berdyshev","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaci.2022.02.027_bib22","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav2685","article-title":"The nonlesional skin surface distinguishes atopic dermatitis with food allergy as a unique endotype","volume":"11","author":"Leung","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaci.2022.02.027_bib23","doi-asserted-by":"crossref","first-page":"5338","DOI":"10.1038\/ncomms6338","article-title":"Identification of the phytosphingosine metabolic pathway leading to odd-numbered fatty acids","volume":"5","author":"Kondo","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2022.02.027_bib24","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.bbalip.2013.08.010","article-title":"The role of sphingolipid metabolism in cutaneous permeability barrier formation","volume":"1841","author":"Breiden","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jaci.2022.02.027_bib25","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.molmed.2019.04.001","article-title":"Epidermal lipids: key mediators of atopic dermatitis pathogenesis","volume":"25","author":"Bhattacharya","year":"2019","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.jaci.2022.02.027_bib26","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.jaci.2020.02.021","article-title":"Cutaneous barrier dysfunction in allergic diseases","volume":"145","author":"Leung","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.02.027_bib27","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/exd.13693","article-title":"Primary role of barrier dysfunction in the pathogenesis of atopic dermatitis","volume":"27","author":"Elias","year":"2018","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaci.2022.02.027_bib28","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/jid.2013.364","article-title":"Interferon-gamma decreases ceramides with long-chain fatty acids: possible involvement in atopic dermatitis and psoriasis","volume":"134","author":"Tawada","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2022.02.027_bib29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jdermsci.2017.05.005","article-title":"Altered expression of epidermal lipid bio-synthesis enzymes in atopic dermatitis skin is accompanied by changes in stratum corneum lipid composition","volume":"88","author":"Danso","year":"2017","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaci.2022.02.027_bib30","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.plipres.2016.04.001","article-title":"Synthesis and degradation pathways, functions, and pathology of ceramides and epidermal acylceramides","volume":"63","author":"Kihara","year":"2016","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.jaci.2022.02.027_bib31","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1212\/WNL.0000000000001659","article-title":"Reactivation of herpesvirus under fingolimod: a case of severe herpes simplex encephalitis","volume":"84","author":"Pfender","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jaci.2022.02.027_bib32","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s13365-017-0569-1","article-title":"Prevalence of a history of prior varicella\/herpes zoster infection in multiple sclerosis","volume":"23","author":"Manouchehrinia","year":"2017","journal-title":"J Neurovirol"},{"key":"10.1016\/j.jaci.2022.02.027_bib33","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.cellsig.2006.01.018","article-title":"De novo biosynthesis of dihydrosphingosine-1-phosphate by sphingosine kinase 1 in mammalian cells","volume":"18","author":"Berdyshev","year":"2006","journal-title":"Cell Signal"},{"key":"10.1016\/j.jaci.2022.02.027_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2019.197835","article-title":"The role of sphingosine-1-phosphate signaling in HSV-1-infected human umbilical vein endothelial cells","volume":"276","author":"Graber","year":"2020","journal-title":"Virus Res"},{"key":"10.1016\/j.jaci.2022.02.027_bib35","doi-asserted-by":"crossref","first-page":"6337","DOI":"10.1002\/jcb.26707","article-title":"Nuclear lipid mediators: role of nuclear sphingolipids and sphingosine-1-phosphate signaling in epigenetic regulation of inflammation and gene expression","volume":"119","author":"Fu","year":"2018","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.jaci.2022.02.027_bib36","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s12013-021-01005-9","article-title":"Nuclear sphingosine-1-phosphate lyase generated \u03942-hexadecenal is a regulator of HDAC activity and chromatin remodeling in lung epithelial cells","volume":"79","author":"Ebenezer","year":"2021","journal-title":"Cell Biochem Biophys"},{"key":"10.1016\/j.jaci.2022.02.027_bib37","doi-asserted-by":"crossref","first-page":"662","DOI":"10.2174\/138945008785132402","article-title":"Targeting SphK1 as a new strategy against cancer","volume":"9","author":"Shida","year":"2008","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.jaci.2022.02.027_bib38","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.bbalip.2008.06.002","article-title":"Ceramidases: regulators of cellular responses mediated by ceramide, sphingosine, and sphingosine-1-phosphate","volume":"1781","author":"Mao","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jaci.2022.02.027_bib39","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1111\/all.14826","article-title":"Serum sphingosine-1-phosphate is elevated in atopic dermatitis and associated with severity","volume":"76","author":"Sakai","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2022.02.027_bib40","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1194\/jlr.S087163","article-title":"MS-based lipidomics of human blood plasma: a community-initiated position paper to develop accepted guidelines","volume":"59","author":"Burla","year":"2018","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jaci.2022.02.027_bib41","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1194\/jlr.D008532","article-title":"Blood sphingolipidomics in healthy humans: impact of sample collection methodology","volume":"51","author":"Hammad","year":"2010","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jaci.2022.02.027_bib42","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1096\/fj.201600788RR","article-title":"Sphingosine-1-phosphate receptor 1 mediates elevated IL-6 signaling to promote chronic inflammation and multitissue damage in sickle cell disease","volume":"32","author":"Zhao","year":"2018","journal-title":"FASEB J"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674922002962?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674922002962?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:37:28Z","timestamp":1758793048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674922002962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0091674922002962"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2022.02.027","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Signaling sphingolipids are biomarkers for atopic dermatitis prone to disseminated viral infections","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2022.02.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}